Ho K.K.Y., Weissberger A.J. (1994) Characterization of 24-hour growth hormone secretion in acromegaly: Implications for diagnosis and therapy. Clin Endocrinol (Oxf) 41:75-83.
Chapman I.M., Hartman M.L., Straume M. (1994) Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower post-glucose nadir GH concentrations in men than women. J Clin Endocrinol Metab 78:1312-1319.
Melmed S., Jackson I., Kleinberg D., Klibanski A. (1998) Current treatment guidelines for acromegaly. J Clin Endocrinol Metab 83:2646-2652.
Duncan E., Wass J.A. (1999) Investigation protocol: Acromegaly and its investigation. Clin Endocrinol (Oxf) 50:285-293.
Chang-DeMoranville B.M., Jackson I.M. (1992) Diagnosis and endocrine testing in acromegaly. Endocrinol Metab Clin North Am 21:649-668.
Freda P.U., Post K.D., Powell J.S., Wardlaw S.L. (1998) Evaluation of disease status with sensitive measures of GH secretion in 60 post-operative patients with acromegaly. J Clin Endocrinol Metab 83:3808-3816.
Irie M., Tsushima T. (1972) Increase of serum growth hormone concentration following thyrotropin-releasing hormone injection in patients with acromegaly or gigantism. J Clin Endocrinol Metab 35:97-100.
Gelato M.C., Merrian G.R., Vance M.L. (1985) Effects of growth hormone-releasing factor on growth hormone secretion in acromegaly. J Clin Endocrinol Metab 60:251-257.
Wu Z., Bidlingmaier M., Dall R., Strasburger C.J. (1999) Detection of doping with human growth hormone. Lancet 353:895.
Jones J.I., Clemmons D.R. (1995) Insulin-like growth factors, and their binding proteins: Biological actions. Endo Rev 16:3-26.
Grinspoon S., Clemmons D., Swearingen B., Klibanski A. (1995) Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly. J Clin Endocrinol Metab 80:927-932.
Ciric I., Ragin A., Baumgartner C., Pierce D. (1997) Complications of transsphenoidal surgery: Results of a national survey, review of the literature, and personal experience. Neurosurgery 40:225-236.
Freda P.U., Wardlaw S.L., Post K.D. (1998) Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly. J Neurosurg 89:353-358.
Swearingen B., Barker F.G., Katznelson L. (1998) Long-term mortality after transsphenoidal surgery, and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 83:3419-3426.
Abosch A., Tyrrell J.B., Lamborn K.R., Hannegan L.T., Applebury C.B., Wilson C.B. (1998) Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: Initial outcome and long-term results. J Clin Endocrinol Metab 83:3411-3418.
Davis D.H., Laws E.R., Ilstrup M.S. (1993) Results of surgical treatment for growth hormone-secreting adenomas. J Neurosurg 79:70-75.
Laws E.R. Jr., Thapar K. (1999) Pituitary surgery in advances in pituitary tumor therapy.28:119-131.
Lamberts S.W.J., Van der Lely A.-J., De Herder W.W., Hofland L.J. (1996) Octreotide. N Engl J Med 334:246-254.
Newman C., Melmed S., George A. (1998) Octreotide as primary therapy for acromegaly. J Clin Endocrinol Metab 83:3104-3109.
Lancranjan I., Atkinson A.B. (1999) Results of a European multicentre study with Sandostatin LAR in acromegalic patients. Pituitary 1:105-114.
Caron P., Morange-Ramos I., Cogne M., Jaquet P. (1997) Three-year follow-up of acromegalic patients treated with intramuscular slow-release lanreotide. J Clin Endocrinol Metab 82:18-22.
Jaffe C.A., Barkan A.L. (1992) Treatment of acromegaly with dopamine agonists. Endocrinol Metab Clin North Am 21:713-735.
Abs R., Verhelst J., Maiter D. (1998) Cabergoline in the treatment of acromegaly: A study in 64 patients. J Clin Endocrinol Metab 83:374-378.
Chen W.Y., Chen N., Yun J., Wagner T.E., Kopchick J.J. (1994) In vitro and in vivo studies of antagonistic effects of human growth hormone analogs. J Biol Chem 269:15.
Eastman R.C., Gorden P., Glatstein E. (1992) Radiation therapy of acromegaly. Endocrinol Metab Clin North Am 21:693-712.
Barkan A.L., Halasz I., Dornfeld K.J. (1997) Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly. J Clin Endocrinol Metab 82:3187-3191.
Landolt A.M., Haller D., Lomax N. (1998) Stereotactic radiosurgery for recurrent surgically treated acromegaly, comparison with fractionated radiotherapy. J Neurosurg 88:1002-1008.
Rajasoorya C., Holdaway I.M., Wrightson P., Scott D.J., Ibbertson H.K. (1994) Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf) 41:95-102.
Bates A.S., Van't Hoff W., Jones J.M., Clayton R.N. (1993) An audit of outcome of treatment in acromegaly. Q J Med 86:293-299.
Bates A.S., Van't Hoff W., Jones J.M., Clayton R.N. (1995) Does treatment of acromegaly affect life expectancy?. Metabolism 44:1-5.
Jenkins P.J., Fairclough P.D., Richards T. (1995) Acromegaly, colonic polyps and carcinoma. Clin Endocrinol (Oxf) 43:517-522.
Melmed S. (1998) Tight control of growth hormone: An attainable outcome for acromegaly treatment. J Clin Endocrinol Metab 83:3409-3410.